Hunan Jiudian Pharmaceutical Co Ltd (300705) — Cash Flow-to-Debt Ratio
Hunan Jiudian Pharmaceutical Co Ltd (300705) has a Cash Flow-to-Debt Ratio of 0.18x as of September 2025, meaning its operating cash flow of CN¥180.33 Million could theoretically repay 0% of its total liabilities (CN¥1.02 Billion) in one year. Check Hunan Jiudian Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hunan Jiudian Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Hunan Jiudian Pharmaceutical Co Ltd across 12 annual periods. Also explore Hunan Jiudian Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hunan Jiudian Pharmaceutical Co Ltd (2013–2024)
Year-by-year debt coverage analysis for Hunan Jiudian Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Hunan Jiudian Pharmaceutical Co Ltd (300705) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.88x | CN¥746.36 Million | CN¥846.40 Million | ▲ +83.6% |
| 2023 | 0.48x | CN¥431.19 Million | CN¥897.93 Million | ▲ +33.4% |
| 2022 | 0.36x | CN¥268.99 Million | CN¥747.05 Million | ▲ +21.8% |
| 2021 | 0.30x | CN¥190.87 Million | CN¥645.90 Million | ▼ -41.9% |
| 2020 | 0.51x | CN¥149.99 Million | CN¥295.04 Million | ▲ +73.8% |
| 2019 | 0.29x | CN¥90.74 Million | CN¥310.23 Million | ▼ -3.5% |
| 2018 | 0.30x | CN¥68.23 Million | CN¥225.05 Million | ▼ -58.9% |
| 2017 | 0.74x | CN¥80.42 Million | CN¥108.95 Million | ▼ -1.5% |
| 2016 | 0.75x | CN¥55.18 Million | CN¥73.60 Million | ▲ +48.6% |
| 2015 | 0.50x | CN¥32.20 Million | CN¥63.81 Million | ▼ -1.6% |
| 2014 | 0.51x | CN¥30.11 Million | CN¥58.71 Million | ▲ +27.5% |
| 2013 | 0.40x | CN¥30.69 Million | CN¥76.30 Million | — |